We have analyzed ligand-receptor complexes resulting from (i) the incubation of canine hepatic plasma membranes with [12'I5iodoglucagon and (ii) subsequent gentle solubilization of receptor-bound ligand with digitonin. The complexes (molecular weight 500,000) retain the radiolabeled ligand during gel filtration and subsequent manipulation at 40C in the absence of covalent crosslinking. Affinity chromatography of the glucagon-receptor complexes on columns of wheat germ lectin linked to agarose resulted in two fractions, one of which was not bound by the column and the other of which was specifically eluted by N-acetylglucosamine. The presence of GTP during the incubation of plasma membranes with [125I]iodoglucagon caused about a 50% decrease in total ligand binding but affected only the ligand-receptor complexes that bound to wheat germ lectin. Moreover, it was found that the proportion of the two forms of ligand-receptor complexes identified by chromatography on wheat germ lectin depended on the degree of saturation of the membrane receptor. Thus, both the inhibition by glucagon of radiolabeled glucagon binding to membranes and the concomitantly decreased extent of association of the radiolabeled ligand with solubilized receptor complexes could be modeled in terms of two noninteracting receptor populations (having dissociation constants of about 0.35 and 4.94 x 10-9 M). We conclude that (i) glucagon-receptor complexes formed on canine hepatic plasma membranes exist in two forms that differ after solubilization by digitonin in their avidities for wheat germ lectin, (a) the highand low-affinity binding of glucagon characteristic of hepatic plasma membranes arises from distinct receptor populations that probably differ in glycosylation, and (Uii) the effect of GTP to decrease binding of glucagon to membranes arises from interactions of the nucleotide with the receptor complex that binds to wheat germ lectin.
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Although the binding ofligand to plasma membrane receptors is known to initiate the mechanism of peptide hormone action, many details ofligand-receptor interactions remain to be clarified. Such interactions often fail to conform to those expected for single binding equilibria, and it has been noted that this deviation from the simple case is particularly acute in the binding of glucagon to hepatic plasma membranes and to surface receptors of isolated hepatocytes (1) (2) (3) (4) (5) (6) : as much as a 50,000-fold increase in the concentration of hormone is required to cause a reduction from 90% to 10% of maximal binding of [125I] iodoglucagon, whereas theory predicts that a 100-fold increase should be sufficient for a single binding equilibrium. In fact, the complex binding of glucagon both to rat hepatocytes and to canine hepatocytes has been successfully modeled in terms of two noninteracting populations of receptors having different affinities for the ligand (1, 3, 5) . In the case of canine hepatocytes, cells that appear to bind glucagon with a notable degree of complexity, high-and low-affinity receptor populations were calculated to have dissociation constants of about 0.5 and 100 x 10-9 M for the hormone and to represent about 1% and 99% oftotal glucagon receptors, respectively (3) .
Since the complex binding of glucagon to plasma membrane receptors has not been uniformly observed (7, 8) and since both negative and positive homotropic interactions have been suggested to play roles in the binding of glucagon to receptor (4, 9, 10) , the validity of mathematical models involving two populations of glucagon receptors has yet to be placed within a biochemical framework. Nevertheless, the hepatic glucagon receptor has been identified as a protein with an apparent molecular weight of 60,000 (11) (12) (13) (14) , and other studies have demonstrated (i) the interaction of the receptor with additional membrane components during hormonal activation of adenylyl cyclase and (ii) the importance of GTP in both increasing the activity of that enzyme and decreasing the affinity of the receptor for glucagon (9, (15) (16) (17) (18) (19) . Indeed, findings placing the glucagon receptor within multimeric complexes of membrane-associated proteins (20) permit consideration of the receptor as existing in two or more states of both physical complexity and affinity.
The aim of the present study was to examine, by biochemical techniques, glucagon receptors of canine hepatic membranes and to reconcile the kinetics of glucagon-receptor interactions with the nature of membrane receptors and associated proteins. As detergent-solubilized glucagon receptors appear to bind the radiolabeled ligand rather poorly (refs. 11, 15, cf. ref. 14) , and as the alffinities of glucagon receptors appear to be modulated by their environment (3), we specifically examined ligand-receptor complexes resulting from the prior association of glucagon to hepatic plasma membranes. Complexes were gently solubilized with digitonin and were analyzed without disruption of their macromolecular components. Affinity chromatography on lectin columns separated the gel-filtered hormone-receptor complexes into two forms. Further analysis showed that (i) the effect of GTP to decrease hormone binding to plasma membranes arises from its interaction with the receptor complex that shows highest avidity for the N-acetylglucosamine-directed lectin, (ii) the high-and low-affinity binding sites for glucagon that are characteristic of the hepatic plasma membrane result from distinct receptor complexes that differ in their binding to wheat germ lectin, and (iii) the complexity of ligand interaction with hepatic glucagon receptors most probably arises from the summed interaction of glucagon with each receptor population.
MATERIALS AND METHODS
Membrane Isolation and Incubation. Hepatic plasma membranes were isolated from canine liver as described by Neville (21) and Ray (22 were treated with the detergent solutions (data not shown). Treatment with digitonin at 1% (wt/vol) reproducibly led to apparently uniform, high molecular weight complexes, which were unlikely to have undergone dissociation of receptor components. Fig. 1 shows the profile obtained from gel filtration ofdigitonin-solubilized I-labeled glucagon-receptor complexes on Sepharose CL-6B. Most ofthe radioactivity (80%6) eluted was associated with proteins having an apparent molecular weight of about 500,000; the elution ofthis material preceded that of the major fraction of digitonin-solubilized membrane proteins. Importantly, when the addition of 1251_ labeled glucagon was delayed until just before the solubilization of membranes, radioactivity was eluted from gel filtration columns at the position taken by 125I-labeled glucagon (Fig. 1) . Additional control studies showed that (i) radioactivity appearing in the low molecular weight fractions was further decreased by washing the pellet a second time after incubation of plasma membranes with 1251-labeled glucagon,
(ii) the high molecular weight material maintained its elution position during rechromatography on Sepharose CL-6B, and (iii) identical profiles were obtained for membranes treated with 0.25, 0.5, 1.0, and 2.0%o solutions of digitonin. These findings demonstrate the inability of the ligand to associate nonspecifically with either high molecular weight proteins or detergent micelles during solubilization and the stability of the ligand-receptor complexes subsequent to solubilization. Further, the high molecular weight of the soluble material suggested that it contained, in addition to the glucagon receptor itself (11, 12, 14) , other receptor-associated proteins in multimeric soluble complexes (11, 12, 16, 20 
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The high molecular weight complexes identified above were applied to a variety of lectin columns in order to assess heterogeneity in soluble components to which 125I-labeled glucagon had been bound. Whereas columns of concanavalin A apparently bound the material irreversibly, Fig. 2A shows that columns of wheat germ lectin separated the radiolabeled material into two fractions, one of which did not bind to lectin (45% of the total) and the other of which was biospecifically eluted by buffers containing N-acetylglucosamine (55% ofthe total). Importantly, the fraction of soluble ligand-receptor complexes retained by the lectin did not depend on the choice of radiolabeled probe: 57, 51, and 55% of soluble complexes were retained by and were specifically eluted from columns of wheat germ lectin subsequent to incubation of membranes with 125I-labeled glucagon in the presence of 0.03 mM GTP [an effector known both to decrease the binding of glucagon to plasma membranes and to induce a lower average affinity state of the receptor (9, (15) (16) (17) (18) (19) ] showed that the nucleotide specifically decreased association of ligand with only the fraction that bound to wheat germ lectin ( Fig. 2A) . Control studies illustrated in Fig. 2B further showed that both receptor fractions retained their properties during both regel-filtration and reapplication to the affinity column. Therefore, we could exclude the possibility that the heterogeneity of the receptor-ligand complexes identified by affinity chromatography could be due to nonspecific binding of material to the lectin columns, dissociation of the ligand-receptor complex, degradation of soluble complexes, or overloading of the affinity matrix. Fig. 3 presents a more complete analysis of the effect of guanyl nucleotides on 125I-labeled glucagon binging to plasma membranes and on association of the ligand with the two populations of ligand-receptor complexes identified by affinity chromatography. Plasma membranes incubated with radiolabeled glucagon and either GTP or its analog guanyl-5'-yl imidophosphate bound progressively less ligand as the (Fig. 1) , and the high molecular weight proteins were reapplied to affinity chromatography columns. Vertical arrows indicate the introduction of N-acetylglucosamine. concentration of nucleotide was increased from 3 nM to 0.3 mM (Fig. 3A) . The concentration of nucleotide causing half maximal effect was about 6.5 /uM in both cases, and in both cases the inhibition of radiolabeled glucagon binding to membrane receptors reached a plateau at higher concentrations of the effector. Fig. 3 (Fig. 4B) . Therefore, as has been proposed Biochemistry: Mason for other systems (1, 3, 5, 11, (27) (28) (29) , the binding of glucagon to canine hepatic membranes and the retention of glucagon by solubilized receptors might best be described in terms of multiple populations of receptors. The consistency of the data shown in Fig. 4A permitted analysis of the association of glucagon with solubilized receptor complexes by using the mathematical model previously derived to describe the binding of glucagon to canine hepatocytes as a result of two noninteracting receptor populations (3). Calculated dissociation constants reflecting retention of ligand by the soluble, gel-filtered complexes are 0.35 ± 0.12 and 4.94 ± 2.67 x 10-9 M for high (Kdl) and low (Kd2) affinity receptor populations, respectively.* The derived constants reflecting the proportions of 125i-labeled glucagon bound to receptors in the absence of competitor are 0.61 ± 0.14 (P1) for association with the high-affinity population and 0.39 ± 0.14 (P2) for association with the lowaffinity population. The theoretical curve derived from the model is shown as the broken line in Fig. 4A and closely matches the experimental data points (A in Fig. 4A ). Although the value for the dissociation constant of the highaffinity receptor is similar to that for the binding of glucagon to the high-affinity receptor population of isolated hepatocytes (0.5 x 10-9 M), the binding of glucagon to the low-affinity receptor population, a parameter notably dependent on receptor environment (3), is markedly decreased.
We finally examined the importance of glucagon concentration and, therefore, receptor saturation on the association of ligand with the two forms of hormone-receptor complexes identified by use ofgel filtration and affinity chromatography. Analysis of material obtained from membranes incubated with '25I-labeled glucagon and with unlabeled glucagon showed that low concentrations of the competitor caused radioactivity in the fraction specifically bound to the lectin column to decrease markedly, whereas higher concentrations of competitor were required to decrease radioactivity in the unbound fraction. A quantitative analysis of the effect of ligand concentration on association of 125I-labeled glucagon with glucagon-receptor complexes separated by affinity chromatography is presented in Fig. 5 . For complexes bound to the lectin column, 0. (11) (12) (13) (14) , with the occurrence of the receptor as part of a multimeric complex of proteins (9, (15) (16) (17) (18) (19) (20) , and with the possible existence of receptor dimers in the plasma membrane (14) . Experiments assessing the effects of GTP on ligand-receptor interactions provide additional information on the kinetics of glucagon association with plasma membrane receptors and on the nature of the high molecular weight complexes identified by use of our methods. Thus, analysis of soluble glucagon-receptor complexes has shown that the well-documented effect of GTP to decrease glucagon binding to plasma membranes (9, (15) (16) (17) (18) (19) arises from a defined loss of hormone association with receptor complexes that are specifically retained by columns of wheat germ lectin-that is, receptor complexes that have been identified as giving rise to the high-affinity interactions of the hormone with plasma membrane receptors.
Although chemical dissection of the high molecular weight glucagon-receptor complexes identified here will require considerable further investigation, our findings form a base for determining the identity of receptor components that (i) provide for ligand recognition in the two populations of glucagon-receptor complexes, (ii) determine the affinity of the receptor for glucagon in each case, (iii) confer specific binding of the high-affinity complex to wheat germ lectin, (iv) result in sensitivity ofthe receptor to the nucleotide GTP, and (v) modulate both binding and biological activities. In fact, the participation of multiple forms of plasma membrane receptors in the binding of ligand to a variety of cells appears not to be unique for the interactions of glucagon with canine hepatic membranes. Thus, very recent reports have documented, by the use of both chemical and physical methods, heterogeneity in receptor populations serving for the interactions of catecholamines with 1321N1 human astrocytoma cells (30) , insulin with Fao/Reuber H35 rat hepatoma cells (31) , dopamine with bovine anterior pituitary (32) , and angiotensin with rat liver plasma membranes (33) . It will be important to assess further the extent to which receptor heterogeneity (perhaps in conjunction with homotropic interactions and potential interconversion of receptor forms) contributes to the kinetic complexity ofhormone interactions with target cells and to the mechanisms by which target cells respond to receptor-bound ligand.
